13D Filing: OrbiMed Advisors and Selecta Biosciences Inc (SELB)

Page 3 of 12

Page 3 of 12 – SEC Filing

CUSIP No. 816212104
1
NAME OF REPORTING PERSON

OrbiMed Capital GP III LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS

AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
SOLE VOTING POWER

0
8
SHARED VOTING POWER

1,831,928 (1)
9
SOLE DISPOSITIVE POWER

0
10
SHARED DISPOSITIVE POWER
                     
1,831,928  (1)
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                     
1,831,928  (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                          
8.30% (2)
14
TYPE OF REPORTING PERSON (See Instructions)

OO
(1) Includes (i) 1,825,415 outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Selecta Biosciences, Inc., a Delaware corporation (the “Issuer”), and (ii) 6,513 Shares issuable upon the exercise of warrants to purchase shares (the “Warrants”).
(2) This percentage is calculated based upon 22,074,378 shares of Issuer, as set forth in the Issuer’s Form 10-Q, filed with the Securities and Exchange Commission (the “SEC”) on August 11, 2017, and includes 6,513 Warrants.

Follow Cartesian Therapeutics Inc.

Page 3 of 12